to create cards to support and brighten the journey of people with cancer.
This #WorldCancerDay learn how organizations around the world are working together to create a future without cancer 3/3 https://worldcancerday.org
We are generating more actionable evidence to reduce the time to bring therapies to market, better treatment decisions, and drive improved outcomes for patients.
Transforming cancer care takes all of us—and often, the real change is felt at a more personal level. 2/3
This year’s #WorldCancerDay theme, #ClosetheCareGap, speaks deeply to our vision: to build a world where technology and science close the gap between care and research. We know the steps required to do just that start with reimagining the infrastructure of cancer care. 1/3
!
With prese Booth #1023 cussing trial data management and using RWD to design & execute more optimized trials, we are motivated to solve specific pain points in the CR space.
Join us ➡️ Booth#1023 #SCOPE2023
, showcasing how we are leveraging our legacy in point-of-care technology to reimagine how clinical trials are executed.
Join us to learn how our product portfolio is bridging the gap between research and care.
Large cohort study of pts w/advanced NSCLC showed rapid integration of immune checkpoint inhibitor immunotherapy across all age groups after FDA approval, but improvements in survival were seen in younger patients & not observed in pts 75 & older. https://ja.ma/403GJRx#LCSM
Flatiron's employee led Green Task Force exemplifies our corporate value ‘do the right thing.’
To learn how Flatiron employees are finding ways to apply their time, talents, & creativity at work to fight #climatechange, read our newest blog: http://spkl.io/60174w9sT
As we continue our impact on #ClinicalResearch, we’re excited to evolve our EDC system beyond traditional EDCs—with greater speed, interoperability, & reliability to get analysis-ready data, sooner.
Learn how our CR offerings are growing in 2023 https://page.flatiron.com/clinical-research-contact…
Flatiron Health CEO Carolyn Starrett has issued a call to the entire healthcare industry: the time to embrace data and technology is now. Read the full transcript of her speech, presented at #HLTH2022, here: http://spkl.io/60124w334
Technology has the power to support changes needed to reduce #clinicalresearch site burden, especially related to data collection. http://spkl.io/60154ZhAP
Connect with our team to discuss how our EHR-to-EDC tech is changing the future of clinical research
dicusses some of the projects the data science team work on, the progress Flatiron have made within #ML in the past two years & much more
🎧 Listen now 👇👇👇
As we reflect on 2022 and look ahead to #2023, we couldn’t be more grateful to all those at Flatiron who have wholeheartedly committed to making a difference across the cancer care ecosystem, from research to the point of care.
At Flatiron, this came in the form of celebrating our 10-year anniversary, evolving our #clinicaltrial solutions, expanding internationally, and using #DataForGood to improve and extend lives by learning from the experience of every person with cancer. ➡️
#2022 wasn’t without challenges, but it’s also been full of hope and progress.
We gathered with loved ones, collaborated in the office, embraced flexibility in hybrid work models, engaged with new team members, and found new ways to learn and grow. ➡️
in one of their recently proclaimed 'Top 25 Stories of 2022.'
Read for a reflection on Flatiron’s last decade and the vision for what’s on the horizon.
Across our research presented at #ASH22, Flatiron leveraged technology to learn from patients w/ hematologic malignancies, breaking barriers for rare populations to advance research & access to trials.
Read insights from Erlene Seymour, MD, to learn more
Congrats to Medical Director, Erlene Seymour for her panel, “Epidemiology: Leveraging Digital Technology to Modernize and Enhance Observational Studies,” at #ASH22!
Interested in learning more about Flatiron authored research? Read insights from Erlene
today for the “Decentralization and Digitalization: Improving Access with Technology” panel at #ASH22 at 3:15pm CT
Interested in learning more about Flatiron authored research? Read insights from Medical Director, Erlene Seymour
At this year's #ASH22, Flatiron leveraged technology to learn from patients w/ hematologic malignancies, breaking barriers for rare populations to advance research & access to trials.
Read for a sneak peak into the research we're presenting this weekend
To understand a person's full history with cancer, Flatiron links EHR data to other sources, from mortality to insurance claims, helping researchers make the most of #RWD and #RWE
Learn more about evidence generation through claims-linked data:
While EHRs are regarded as the definitive record of a person’s history with cancer, they may not capture the full story.
Learn more about how Flatiron is leading innovative approaches to evidence generation through claims-linked data:
Register today for the #RueschSymposium keynote with @NealMeropol of @flatironhealth on Friday, November 18th at 12PM ET. Join us in person or virtually using promo code Guest2022. http://bit.ly/Ruesch2022.
@LombardiCancer@MedStarGUH@OncLive
CEO, Carolyn Starrett, for her presentation at #HLTH2022!
She shared how we're using latest breakthroughs in #realworldevidence, #machinelearning, and #AI to shape the future of cancer care for clinicians, researchers and patients alike.
Flatiron Health CEO Carolyn Starrett will be presenting at #HLTH2022 tomorrow!
🗓️Join her on The Seaport Stage @ 10:10 AM to learn how Flatiron is using data and technology to reimagine the infrastructure of cancer care.
CTAC proposed guidelines for streamlining data collection requirements for clinical trials.
Neal, Co-Chair of the NCI’s Working Group on Streamlining Clinical Trials, shared his thoughts:
https://cancerletter.com/clinical/20221111_1/…
T-5 Days until #HLTH2022! It's going to be EPIC
We are expecting 9,500+ health innovators from 47 countries!
From captivating sessions to interactive activations and networking receptions for every audience, we have so much in store for you http://ow.ly/tyun50Lxu0o
Visit the Flatiron Evidence Desk to learn more about our compelling research presented at #ISPOREurope 2022, including: Bias characterization of real-world patients with and without imaging in a community oncology Electronic Health Record-derived database.
http://bit.ly/3zS8cdt
spoke to the future of RWD and ML in an #ISPOREurope issue panel, “RWD at Scale: How ML Can Enable Learning from All Patients”
For examples of ML at work, visit the Evidence Desk to learn about our 2022 ISPOR EU research
researchers on their #ISPOREurope presentation, 'Comparison of Comorbidity Indices Between EHR Derived Database & Claims Data Among Patients w/ mBC'
Head over to abstract #SA27, or visit http://bit.ly/3zS8cdt, to learn about the impact of this work!
, where the future of health happens, to learn how the latest breakthroughs in real-world evidence, machine learning, and AI are shaping the future of cancer care for clinicians, researchers and patients alike. #HLTH2022